Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Mirco Compagnone
The BET-bromodomain Inhibitor JQ1 Renders Neuroblastoma Cells More Resistant to NK Cell-Mediated Recognition and Killing by Downregulating Ligands for NKG2D and DNAM1 Receptors
Oncotarget
Oncology
Related publications
The Bromodomain BET Inhibitor JQ1 Suppresses Tumor Angiogenesis in Models of Childhood Sarcoma
Molecular Cancer Therapeutics
Cancer Research
Oncology
Increase of NKG2D Ligands and Sensitivity to NK Cell-Mediated Cytotoxicity of Tumor Cells by Heat Shock and Ionizing Radiation
Experimental & Molecular Medicine
Sensitization of Tumor Cells to NK Cell-Mediated Killing by Proteasome Inhibition
Journal of Immunology
Allergy
Immunology
A Role for NKG2D in NK Cell–Mediated Resistance to Poxvirus Disease
PLoS Pathogens
Immunology
Molecular Biology
Virology
Microbiology
Parasitology
Genetics
NKG2D Signaling Leads to NK Cell Mediated Lysis of Childhood AML
Journal of Immunology Research
Medicine
Allergy
Immunology
The Requirement for DNAM-1, NKG2D, and NKp46 in the Natural Killer Cell-Mediated Killing of Myeloma Cells
Cancer Research
Cancer Research
Oncology
Nanog Requires BRD4 to Maintain Murine Embryonic Stem Cell Pluripotency and Is Suppressed by Bromodomain Inhibitor JQ1 Together With Lefty1
Stem Cells and Development
Developmental Biology
Hematology
Cell Biology
Cutting Edge: Tumor-Targeting Antibodies Enhance NKG2D-Mediated NK Cell Cytotoxicity by Stabilizing NK Cell-Tumor Cell Interactions
Journal of Immunology
Allergy
Immunology
The Interaction Between CD300a and Phosphatidylserine Inhibits Tumor Cell Killing by NK Cells
European Journal of Immunology
Allergy
Immunology
